Episode 31: (Part I) Clinical Trials - Expectations vs. Realities
In this two-part series, we reprise “Navigating Clinical Trials: Expectations vs. Realities” with Taymeyah Al-Toubah. This was previously broadcast on August 19th, 2023, as a LACNETS monthly education...
14 Mar 202435min
Episode 31: (Part II) Clinical Trials - Expectations vs. Realities
In this two-part series, we reprise “Navigating Clinical Trials: Expectations vs. Realities” with Taymeyah Al-Toubah. This was previously broadcast on August 19th, 2023, as a LACNETS monthly education...
14 Mar 202440min
Episode 30: Bone & Brain Metastases in Neuroendocrine Cancer
When and how often do NETs spread to the bones or brain? How are they found? What is the treatment? Dr. Robert Ramirez of Vanderbilt University addresses concerns surrounding bone metastases (or “mets...
15 Feb 202443min
Episode 29: "Nutrition & Diet Considerations for NET" with Sina Teskey
NET dietician Sina Teskey from the Medical College of Wisconsin answers common questions about diet and nutrition raised among NET patients and caregivers. She addresses special diets, food restrictio...
15 Jan 202445min
Top 10 Highlights of 2023 NANETS Symposium
In this special episode, Oregon Health & Sciences University (OHSU) Medical oncologist, Dr. Guillaume (Will) Pegna, recaps the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplina...
11 Des 20231h
Episode 27: What to Know About Neuroendocrine Tumor Liver Metastases
What do you call NETs in the liver? How often do NETs spread? What causes NETs to spread? How do you determine if surgery is an option? Dr. Xavier Keutgen from University of Chicago brings clarity to ...
15 Nov 202346min
Episode 26: What to Know About Lung NETs
What are lung NETs? What is DIPNECH? How is lung NET similar or different from lung cancer? Dr. Vineeth Sukrithan from Ohio State University Comprehensive Cancer Center gives a comprehensive overview ...
15 Okt 202344min
Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)
What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City expl...
15 Sep 202345min
